Claya review

Claya for moms: our verdict

$149/mo semaglutide or $199/mo tirzepatide on its recommended Monthly Plan, from two named compounding pharmacies, with a real published cancellation policy (2 days' notice) — one of the more transparent compounders reviewed, though its oral-tablet price wasn't cleanly confirmed. It runs about $149/mo, flat across every dose — toward the affordable end of what we track.

We looked at Claya the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What Claya actually costs

• Compounded semaglutide — Monthly Plan (recommended): $149/mo
• Oral semaglutide — Oral tablet: $279/mo
• Compounded tirzepatide — Monthly Plan (recommended): $199/mo

That lands below the median ongoing price of about $177 across the providers we track for moms — a real cost advantage.

Claya prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.

That price covers the consult, the medication and shipping.

The medications Claya prescribes

Claya lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.

If you prefer an option without needles, check the exact product offered. FDA-approved oral semaglutide tablets have their own clinical trials and prescribing labels. Compounded oral or sublingual products are different: they are not FDA-approved and cannot be assumed equivalent to an approved tablet or injection. Ask the clinician about the formulation, evidence and instructions.

Where it operates. Claya publishes no state list, so confirm it serves yours before you pay anything.

Where Claya fits — and where it doesn't — for moms

A good fit if…

• the monthly cost is a real barrier and you want a low, predictable number.
• you want to discuss both semaglutide and tirzepatide with your prescribing clinician.

Look elsewhere if…

• you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
• you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.

Trust, safety and oversight

Our confidence in Claya's public data is high — the pricing, the pharmacies and the clinical network were all verifiable at our last review. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

Claya is a genuine bargain for the price — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.